
AMETEK (AME) Stock Forecast & Price Target
AMETEK (AME) Analyst Ratings
Bulls say
AMETEK is well positioned by its portfolio of more than 40 autonomous industrial businesses serving durable niches in research, aerospace, energy, medical, and manufacturing, where differentiated products and market leadership support resilient demand and pricing power. Its 3Q’26 results reinforced that advantage, with sales up 17%, adjusted EPS up 17% to $2.21, operating income up 20%, core margins expanding to 27.3%, and record backlog of $4.54B backed by 35% order growth and 124% free-cash-flow conversion. The company also appears to have substantial self-funded growth optionality, as strong cash generation and a solid balance sheet support continued M&A while acquisitions like Indicor and Paragon enhance scale, mix, and earnings power.
Bears say
AMETEK is viewed negatively because its heavy exposure to cyclical markets such as oil & gas, industrial, process, and aerospace makes earnings vulnerable to macro deterioration, destocking, and project delays. Its M&A-driven model also creates integration and overpayment risk, while the stated challenge of achieving above average organic growth suggests the company may struggle to offset slower end-market demand and rising material costs with pricing. Valuation leaves little room for error, with shares trading at 26.0x 2027 cash EPS and a 22% premium to peers, despite the risk of multiple compression if execution or demand weakens.
This aggregate rating is based on analysts' research of AMETEK and is not a guaranteed prediction by Public.com or investment advice.
AMETEK (AME) Analyst Forecast & Price Prediction
Start investing in AMETEK (AME)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About AMETEK (AME) Forecast
AMETEK (AME) Analyst Forecast & Price Prediction
Start investing in AMETEK (AME)
Order type
Buy in
Order amount
Est. shares
0 shares